COP

CONOCOPHILLIPSEnergy

10-K for period ending 2025-12-31filed 2026-02-17accession 0001163165-26-000009filing on sec.gov ↗

answer key

field	SEC value	XBRL concept	printed on
Total revenue	$58.9B	Revenues	Sales and other operating revenues
Operating income	-	not reported	not in this filing's XBRL
Net income attributable to the company	$8.0B	NetIncomeLoss	Net income (loss)
Diluted EPS	$6.35	EarningsPerShareDiluted	Diluted
Cash and cash equivalents	$6.5B	CashAndCashEquivalentsAtCarryingValue	Cash and cash equivalents
Total assets	$121.9B	Assets	Total assets · Total liabilities and equity
Total liabilities	$57.5B	Liabilities	Total liabilities
Total shareholders' equity attributable to the company	$64.5B	StockholdersEquity	Total equity
Net cash from operating activities	$19.8B	NetCashProvidedByUsedInOperatingActivities	Net cash provided by operating activities
Net cash from investing activities	-$8.8B	NetCashProvidedByUsedInInvestingActivities	Net cash used in investing activities
Net cash from financing activities	-$10.1B	NetCashProvidedByUsedInFinancingActivities	Net cash used in financing activities

Income statement

table #188 · score 51.3 vs 28.5 runner-up · in millions

Years Ended December 31	Millions of Dollars
2025	2024	2023
Revenues and other income
Sales and other operating revenues	58,944	54,745	56,141
Equity in earnings of affiliates	1,335	1,705	1,720
Gain (loss) on dispositions	731	51	228
Other income	538	452	485
Total revenues and other income	61,548	56,953	58,574
Costs and expenses
Purchased commodities	22,325	20,012	21,975
Production and operating expenses	10,331	8,751	7,693
Selling, general and administrative expenses	893	1,158	705
Exploration expenses	407	355	398
Depreciation, depletion and amortization	11,500	9,599	8,270
Impairments	26	80	14
Taxes other than income taxes	2,146	2,087	2,074
Accretion on discounted liabilities	378	325	283
Interest and debt expense	855	783	780
Foreign currency transaction (gain) loss	11	(50)	92
Other expenses	20	181	2
Total costs and expenses	48,892	43,281	42,286
Income (loss) before income taxes	12,656	13,672	16,288
Income tax provision (benefit)	4,668	4,427	5,331
Net income (loss)	7,988	9,245	10,957
Net income (loss) per share of common stock (dollars)
Basic	6.36	7.82	9.08
Diluted	6.35	7.81	9.06
Weighted-average common shares outstanding (in thousands)
Basic	1,252,042	1,178,920	1,202,757
Diluted	1,253,446	1,180,871	1,205,675

Balance sheet

table #196 · score 52.5 vs 24 runner-up · in millions

At December 31	Millions of Dollars
2025	2024
Assets
Cash and cash equivalents	6,497	5,607
Short-term investments	484	507
Accounts and notes receivable (net of allowance of $4 and $7, respectively)	5,813	6,695
Inventories	1,873	1,809
Prepaid expenses and other current assets	865	1,029
Total current assets	15,532	15,647
Investments and long-term receivables	10,185	9,869
Net properties, plants and equipment (net of accumulated DD&A of $90,396 and $81,072, respectively)	93,239	94,356
Other assets	2,983	2,908
Total assets	121,939	122,780
Liabilities
Accounts payable	6,218	6,044
Short-term debt	1,020	1,035
Accrued income and other taxes	1,835	2,460
Employee benefit obligations	1,136	1,087
Other accruals	1,763	1,498
Total current liabilities	11,972	12,124
Long-term debt	22,424	23,289
Asset retirement obligations and accrued environmental costs	8,214	8,089
Deferred income taxes	12,237	11,426
Employee benefit obligations	969	1,022
Other liabilities and deferred credits	1,636	2,034
Total liabilities	57,452	57,984
Equity
Common stock (2,500,000,000 shares authorized at $0.01 par value) Issued (2025-2,253,518,282 shares; 2024-2,250,672,734 shares)
Par value	23	23
Capital in excess of par	77,728	77,529
Treasury stock (at cost: 2025-1,028,350,186 shares; 2024-974,806,010 shares)	(76,217)	(71,152)
Accumulated other comprehensive income (loss)	(5,911)	(6,473)
Retained earnings	68,864	64,869
Total equity	64,487	64,796
Total liabilities and equity	121,939	122,780

Cash flow statement

table #200 · score 53.5 vs 10 runner-up · in millions

Years Ended December 31	Millions of Dollars
2025	2024	2023
Cash flows from operating activities
Net income (loss)	7,988	9,245	10,957
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation, depletion and amortization	11,500	9,599	8,270
Impairments	26	80	14
Dry hole costs and leasehold impairments	181	46	162
Accretion on discounted liabilities	378	325	283
Deferred taxes	549	367	1,145
Distributions more (less) than income from equity affiliates	200	564	964
(Gain) loss on dispositions	(731)	(51)	(228)
Other	(219)	130	(220)
Working capital adjustments
Decrease (increase) in accounts and notes receivable	803	(262)	1,333
Decrease (increase) in inventories	(116)	(68)	(103)
Decrease (increase) in prepaid expenses and other current assets	(24)	79	337
Increase (decrease) in accounts payable	(212)	(543)	(1,118)
Increase (decrease) in taxes and other accruals	(527)	613	(1,831)
Net cash provided by operating activities	19,796	20,124	19,965
Cash flows from investing activities
Capital expenditures and investments	(12,553)	(12,118)	(11,248)
Working capital changes associated with investing activities	546	302	30
Acquisition of businesses, net of cash acquired	-	(24)	(2,724)
Proceeds from asset dispositions	3,248	261	632
Net sales (purchases) of investments	(55)	415	1,373
Other	(22)	14	(63)
Net cash used in investing activities	(8,836)	(11,150)	(12,000)
Cash flows from financing activities
Issuance of debt	-	5,591	3,787
Repayment of debt	(913)	(4,981)	(1,379)
Issuance of company common stock	(100)	(78)	(52)
Repurchase of company common stock	(5,018)	(5,463)	(5,400)
Dividends paid	(3,995)	(3,646)	(5,583)
Other	(76)	(258)	(34)
Net cash used in financing activities	(10,102)	(8,835)	(8,661)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	153	(133)	(99)
Net change in cash, cash equivalents and restricted cash	1,011	6	(795)
Cash, cash equivalents and restricted cash at beginning of period	5,905	5,899	6,694
Cash, cash equivalents and restricted cash at end of period	6,916	5,905	5,899